Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Integra Lifesciences Holdings (IART) Short-term Investments (2017 - 2025)

Historic Short-term Investments for Integra Lifesciences Holdings (IART) over the last 5 years, with Q3 2025 value amounting to $35.7 million.

  • Integra Lifesciences Holdings' Short-term Investments fell 4282.6% to $35.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $35.7 million, marking a year-over-year decrease of 4282.6%. This contributed to the annual value of $27.2 million for FY2024, which is 1681.96% down from last year.
  • Integra Lifesciences Holdings' Short-term Investments amounted to $35.7 million in Q3 2025, which was down 4282.6% from $35.7 million recorded in Q2 2025.
  • Over the past 5 years, Integra Lifesciences Holdings' Short-term Investments peaked at $81.7 million during Q2 2024, and registered a low of $27.2 million during Q4 2024.
  • Moreover, its 3-year median value for Short-term Investments was $35.7 million (2025), whereas its average is $47.6 million.
  • Its Short-term Investments has fluctuated over the past 5 years, first plummeted by 1681.96% in 2024, then crashed by 5630.35% in 2025.
  • Quarter analysis of 3 years shows Integra Lifesciences Holdings' Short-term Investments stood at $32.7 million in 2023, then dropped by 16.82% to $27.2 million in 2024, then soared by 31.25% to $35.7 million in 2025.
  • Its Short-term Investments stands at $35.7 million for Q3 2025, versus $35.7 million for Q2 2025 and $34.2 million for Q1 2025.